Davis Polk advised the joint book-running managers in the offering. Flex Ltd. executed a $400 million SEC-registered debt offering. The offering consisted of $400 million aggregate principal amount...
Flex’s $400 Million Notes Offering
Amazon.com’s $8.25 Billion Notes Offering
Gibson, Dunn & Crutcher advised Amazon.com, while Davis Polk advised the representatives of the underwriters in the offering. Amazon.com, Inc. executed its offering, consisting of $1.25...
RAPT Therapeutics’ $75 Million Common Stock Offering
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
Natera’s $400 Million Shares Offering
Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Snail’s $15 Million Initial Public Offering
Davis Polk advised Snail on the deal. Snail, Inc. executed its SEC-registered initial public offering of 3,000,000 shares of Class A common stock for total gross...
Equinix’s $1.5 Billion At-The-Market Offering
Davis Polk advised Equinix, Inc. on the offering. Equinix, Inc. announced its SEC-registered at-the-market offering program. Pursuant to the terms of the program, Equinix may issue, offer and/or...
Abiomed’s $18 Billion Merger Agreement with Johnson & Johnson
Sullivan & Cromwell advised Abiomed on the deal, while Cravath represented Johnson & Johnson. Davis Polk advised J.P. Morgan Securities LLC as financial adviser to Johnson...
Recursion Pharmaceuticals’ $150 Million Private Placement
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
Denali Therapeutics’ $316 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
EDAP TMS’s $23 Million Follow-on Offering
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
Allakos’ $150 Million Shares Offering
Davis Polk advised the representatives of the underwriters in the offering. Allakos Inc. announced its offering of 29,882,000 shares of common stock, for total gross proceeds of...